Nihon Kohden Corporation (OTCMKTS:NHNKY) Sees Significant Decrease in Short Interest

Nihon Kohden Corporation (OTCMKTS:NHNKY) saw a significant decrease in short interest in May. As of May 15th, there was short interest totaling 3,556 shares, a decrease of 83.6% from the April 30th total of 21,619 shares. Based on an average daily volume of 39,773 shares, the days-to-cover ratio is presently 0.1 days. Currently, 0.0% of the shares of the company are sold short.

Nihon Kohden Stock Up 2.4%

Shares of NHNKY stock opened at $9.08 on Thursday. The stock has a 50-day simple moving average of $9.40 and a 200 day simple moving average of $10.36. Nihon Kohden has a fifty-two week low of $8.71 and a fifty-two week high of $14.21. The stock has a market capitalization of $1.55 billion, a P/E ratio of 15.39 and a beta of 0.41.

Nihon Kohden (OTCMKTS:NHNKY) last released its quarterly earnings results on Thursday, May 14th. The company reported $0.34 earnings per share for the quarter, beating analysts’ consensus estimates of $0.24 by $0.10. Nihon Kohden had a return on equity of 9.48% and a net margin of 6.08%.The business had revenue of $453.10 million during the quarter, compared to analyst estimates of $414.40 million. On average, sell-side analysts anticipate that Nihon Kohden will post 0.61 earnings per share for the current year.

Analyst Ratings Changes

Separately, Zacks Research raised Nihon Kohden to a “hold” rating in a research note on Monday, April 27th. One equities research analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Buy”.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.